US20040181275A1 - Channeled vascular stent apparatus and method - Google Patents
Channeled vascular stent apparatus and method Download PDFInfo
- Publication number
- US20040181275A1 US20040181275A1 US10/806,263 US80626304A US2004181275A1 US 20040181275 A1 US20040181275 A1 US 20040181275A1 US 80626304 A US80626304 A US 80626304A US 2004181275 A1 US2004181275 A1 US 2004181275A1
- Authority
- US
- United States
- Prior art keywords
- stent
- channel
- machined
- stent element
- cylindrical shape
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
- A61F2002/91541—Adjacent bands are arranged out of phase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
- A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
Definitions
- the present invention generally relates to medical devices, and more particularly relates to devices for reinforcement of a portion of a vascular wall.
- the primary disease effecting the coronary system involves the build-up of material within the lumen of a vessel which partially or completely occludes the vessel preventing adequate perfusion.
- the primary therapies involve invasive procedures.
- PTCA percutaneous translumenal coronary angioplasty
- a catheter is inserted percutaneously into an artery (usually the femoral artery in the leg) and advanced so that the distal portion, containing an inflatable balloon reaches the occluded section of the coronary artery. Inflation of the balloon compresses the occluding material into the vessel wall, thus increasing the effective cross section of the vessel. Because the procedure is much less invasive than by-pass, it is much less costly and much less traumatic.
- a stent is a generally cylindrical structure which fits snugly the inside dimension of the inner vessel wall, providing additional radial strength against restenosis.
- U.S. Pat. No. 4,307,723, issued to Finney describes a stent having a considerably different configuration which is commonly utilized within the urinary tract.
- U.S. Pat. No. 5,989,207 shows a relatively elongate stent structure.
- a stent more specifically configured for coronary use is seen in U.S. Pat. No. 5,879,370, issued to Fischell et al. Frantzen, in U.S. Pat. No. 5,718,713, describes a stent structure produced of a mesh having a flattened outer surface.
- U.S. Pat. No. 5,843,172, issued to Yan describes a stent which is porous to provide chronic release of a drug.
- the present invention overcomes many of the disadvantages found in the prior art by offering a method of and apparatus for providing the desired stent functions yet having improved properties of placement and chronic implantation. These improvements are derived from the fabrication techniques and physical configuration of the stent of the present invention.
- the present invention offers a greater opportunity for positioning and dispensing of medication for chronic drug therapy. It also provides enhanced chronic retention, improved perfusion, and differential flexibility in placement.
- the stent is fabricated from hollow, cylindrical, tube-like stock of a biocompatible material, such as titanium or medical grade stainless steel.
- the raw stock is preferably “machined” on a machine tool having a rotary laser cutting head, which cuts a mesh-like pattern through the wall of the metal stock. It may be appropriate, in certain other applications, to utilize a memory-type metal, such as Nitinol.
- one or more pockets or channels are cut into but not through the stent wall.
- These pockets or channels can greatly enhance the positional stability of the stent, because the channel edges tend to more tightly grip the vessel wall.
- the pockets or channels can incidentally provide a path for blood flow between the outer stent wall and the endothelial cells of the inner vessel wall.
- the present invention can provide enhanced perfusion of the stented vessel wall. This enhanced perfusion would especially benefit stent designs having an embedded medication, because it would generate greater distribution of the drug.
- the pockets or channels may be machined circumferentially or longitudinally with respect to the normal blood flow. Longitudinal orientation would tend to provide the greatest enhancement of perfusion. This will be the configuration for many applications.
- Circumferential orientation of the pockets or channels provides all of the above described benefits and also imparts differential flexibility along the length of the stent. This occurs because the reduced metal of the pocket or channel more readily permits a bend to occur at the location of the channel. This differential flexibility is particularly useful in effective placement of the stent, although it is also helpful in positional retention around bends in the vessel wall.
- One particular embodiment of the present invention provides for differentially machining a stent mesh pattern at one or more selected locations. These breaks are useful for imparting a particular desired degree of differential flexibility.
- FIG. 1 is a diagram schematically showing the overall medical procedure:
- FIG. 2 is a closeup view conceptually showing the operation of a vascular stent
- FIG. 3A is a closeup view conceptually showing a stent machined into a mesh-like pattern
- FIG. 3B is a closeup view of the mesh-like stent further machined with the channels of the present invention.
- FIG. 3C is a closeup view of particular sections of the stent of FIG. 3B;
- FIG. 4 is a very close up sectioned view of the contact between the longitudinally channeled stent element and the vessel wall;
- FIG. 5 is a view similar to FIG. 4 having a medication for chronic therapy
- FIG. 6 is a very close up view of the contact between the laterally channeled stent element and the vessel wall;
- FIG. 7 is a view similar to FIG. 6 having a medication for chronic therapy
- FIG. 8 is a very close up view of the contact between the laterally channeled stent element and the vessel wall showing differential flexibility around a bend in the vessel wall;
- FIG. 9 is a view similar to that of FIG. 8 wherein the stent element has been machined into an articulated bridge.
- FIG. 1 is a diagram 10 schematically showing the overall medical procedure.
- Patient 12 has experienced occlusion 14 of coronary artery 16 . This has caused insufficient perfusion to myocardial tissue 18 of patient 12 .
- the distal portion of a catheter containing a dilation balloon and stent is percutaneously inserted at incision 22 and advanced through artery 20 into coronary artery 16 to occlusion 14 .
- Occlusion 14 is opened and stented in the manner known in the art.
- FIG. 2 is a closeup conceptual view of stent 24 as place after dilatation of occlusion 14 (not shown).
- Stent 24 is generally cylindrical in shape having an inner lumen 26 .
- stent 24 is fabricated from thin, biocompatible tubing of stainless steel, titanium, or Nitinol.
- stent 24 has a length of several millimeters to about one centimeter.
- a pattern (not shown in FIG. 2) is machined in the wall of stent 24 as described below.
- Stent 24 has an outside diameter which is sized to snugly fit within the inner lumen of coronary artery 16 after dilatation.
- FIG. 3A is a close-up view of stent 24 as machined into a mesh-like pattern. Such machining removes much of the mass from the implanted stent.
- the mesh-like pattern increases flexibility of the stent and improves perfusion to the endothelial cells at the inside surface of the vessel wall.
- Stent element 28 appears as a portion of the generally cylindrical surface of stent 24 .
- Stent element 28 has a generally flat outer surface and a generally flat inner surface.
- Stent element 28 is preferably recessed in accordance with one of the embodiments of the present invention as described below in detail.
- FIG. 3B is a closeup view of the mesh-like stent of FIG. 3A further machined to include pockets or channels in accordance with the present invention.
- the basic structure of the mesh-like pattern is a plurality of cells 60 interconnected to provide the desired size.
- Each cell 60 contains strut 54 and internal radial arc 62 .
- the cells are connected via connecting bridge 56 .
- Articulated bridge 58 is further machined as described in more detail below to enhance differential flexibility.
- the ends of stent 24 are defined by a plurality of end radial arcs 64 .
- Section AA provides a closeup (see FIG. 3C) of a machined channel.
- Section BB provides a closeup (see FIG. 3C) of a machined articulated bridge.
- FIG. 3C is a closeup of Section AA, which is a machined channel, and Section BB, which is a machined articulated bridge.
- FIG. 4 is a very close-up sectioned view of stent element 28 (the remainder of stent 24 is not shown for clarity) as chronically implanted.
- stent element 28 is channeled in the longitudinal direction (i.e., direction of blood flow).
- Channel 30 is outwardly concave, as shown. This permits greater perfusion of surface 36 of coronary artery 16 .
- edges 32 and 34 tend to prevent inadvertent repositioning during chronic implantation.
- FIG. 5 is a view similar to that shown in FIG. 6 with the addition of medication 38 within channel 30 .
- Medication 38 is typically an anti-clotting agent, such as TPA, or an anti-irritant, such as a suitable steroid.
- TPA anti-clotting agent
- an anti-irritant such as a suitable steroid.
- the placement of medication 38 within channel 30 enhances chronic dispersion of the drug.
- FIG. 6 is a view similar to FIG. 4, in which stent element 28 (the remainder of stent 24 is not shown for clarity) is channeled laterally (i.e., perpendicular to the direction of blood flow).
- Channel 44 is formed in the same manner as channel 30 (see also FIG. 4), but it is machined perpendicularly.
- Channel 44 , edge 40 , and edge 42 function in the same manner as channel 30 , edge 32 , and edge 34 .
- FIG. 7 is a view similar to FIG. 6 wherein channel 44 contains medication 38 . This embodiment functions similar to the embodiment of FIG. 5.
- FIG. 8 is a view similar to FIG. 6 wherein channel 44 is utilized to provide differential flexibility to stent element 28 .
- This differential flexibility is important in accommodating bend 46 of vessel 16 . This differential flexibility also assists in resisting inadvertent repositioning.
- FIG. 9 is a view similar to FIG. 8 wherein channel 40 has been machined deeply into stent element 28 and wherein the thin region 48 in stent element 28 imparts a particular articulation in stent 24 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Vascular Medicine (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Abstract
A vascular stent having one or more channels in the outer surface. The channel(s) provide increased flexibility, enhanced perfusion, increased chronic positional stability, and convenient dispensing of a medication. Preferably the stent is machined into a mesh-like pattern and the channel(s) are machined into the stent elements of the pattern. The channels may be oriented in a variety of ways. Parallel orientation tends to provide greater enhancement of perfusion whereas perpendicular orientation provides differential flexibility. For greater control of differential flexibility, the channel may be further machined in the stent element, producing a regain of greater flexibility.
Description
- None.
- 1. Field of the Invention
- The present invention generally relates to medical devices, and more particularly relates to devices for reinforcement of a portion of a vascular wall.
- 2. Description of the Prior Art
- It is well known in the prior art to design and build apparatus for the treatment of various vascular disorders. It is common to group these therapies in accordance with the location within the body of the vessel(s) to be treated. For example, peripheral vascular therapies treat vascular disease of the extremities. Similarly, cardiac vascular therapies treat vascular disease of the coronary system. This method of differentiation is particularly helpful in that the medical procedures and corresponding medical devices tend to be specifically tailored to the individual application.
- The primary disease effecting the coronary system involves the build-up of material within the lumen of a vessel which partially or completely occludes the vessel preventing adequate perfusion. Though there are reported attempts in the literature to provide treatment using systemic drugs, the primary therapies involve invasive procedures.
- Perhaps most common, is the by-pass surgical procedure. Most typically this involves a complete thoracotomy during which those sections of the coronary arteries which are partially or completely occluded are surgically removed. If the occluded sections prove to be quite long, it may be necessary to supply artificial or organic graft material. Common artificial grafts are made from woven polymer fibers. Natural grafts may be transplanted from a human or animal donor or may be harvested from the patient, as with the use of the patient's saphenous vein.
- The key alternative to by-pass surgery is a less invasive procedure termed percutaneous translumenal coronary angioplasty (PTCA). In this procedure, a catheter is inserted percutaneously into an artery (usually the femoral artery in the leg) and advanced so that the distal portion, containing an inflatable balloon reaches the occluded section of the coronary artery. Inflation of the balloon compresses the occluding material into the vessel wall, thus increasing the effective cross section of the vessel. Because the procedure is much less invasive than by-pass, it is much less costly and much less traumatic.
- However, the prevalent medical concern about PTCA involves the restenosis rate. A number of preliminary studies have shown that the rate at which treated vessels subsequently reocclude may be unacceptably high. The exact mechanism whereby restenosis occurs is not well understand, notwithstanding considerable on-going research on the topic. Yet, it seems rather intuitive that the vessel wall, in the region of the initial lesion, may have been weakened by the disease. It also seems likely that such a weakened vessel wall may indeed be further weakened by the PTCA procedure, itself.
- Thus, it has become a common practice to supplement the PTCA procedure with the implantation of a stent to provide reinforcement of the vessel wall. A stent is a generally cylindrical structure which fits snugly the inside dimension of the inner vessel wall, providing additional radial strength against restenosis. U.S. Pat. No. 4,307,723, issued to Finney, describes a stent having a considerably different configuration which is commonly utilized within the urinary tract.
- U.S. Pat. No. 5,989,207, issued to Hughes, shows a relatively elongate stent structure. A stent more specifically configured for coronary use is seen in U.S. Pat. No. 5,879,370, issued to Fischell et al. Frantzen, in U.S. Pat. No. 5,718,713, describes a stent structure produced of a mesh having a flattened outer surface. U.S. Pat. No. 5,843,172, issued to Yan describes a stent which is porous to provide chronic release of a drug. With all of these proposed stent structures, there remain the concerns of accomplishment of the basic purpose of the stent implantation, without undue chronic movement and without undue prevention of the perfusion of the endothelial cells of the stented vessel wall.
- The present invention overcomes many of the disadvantages found in the prior art by offering a method of and apparatus for providing the desired stent functions yet having improved properties of placement and chronic implantation. These improvements are derived from the fabrication techniques and physical configuration of the stent of the present invention.
- The present invention offers a greater opportunity for positioning and dispensing of medication for chronic drug therapy. It also provides enhanced chronic retention, improved perfusion, and differential flexibility in placement.
- In the preferred mode of practicing the present invention, the stent is fabricated from hollow, cylindrical, tube-like stock of a biocompatible material, such as titanium or medical grade stainless steel. The raw stock is preferably “machined” on a machine tool having a rotary laser cutting head, which cuts a mesh-like pattern through the wall of the metal stock. It may be appropriate, in certain other applications, to utilize a memory-type metal, such as Nitinol.
- In addition to the pattern cut entirely through the stock, one or more pockets or channels are cut into but not through the stent wall. These pockets or channels can greatly enhance the positional stability of the stent, because the channel edges tend to more tightly grip the vessel wall. The pockets or channels can incidentally provide a path for blood flow between the outer stent wall and the endothelial cells of the inner vessel wall. As a result, the present invention can provide enhanced perfusion of the stented vessel wall. This enhanced perfusion would especially benefit stent designs having an embedded medication, because it would generate greater distribution of the drug.
- The pockets or channels may be machined circumferentially or longitudinally with respect to the normal blood flow. Longitudinal orientation would tend to provide the greatest enhancement of perfusion. This will be the configuration for many applications.
- Circumferential orientation of the pockets or channels provides all of the above described benefits and also imparts differential flexibility along the length of the stent. This occurs because the reduced metal of the pocket or channel more readily permits a bend to occur at the location of the channel. This differential flexibility is particularly useful in effective placement of the stent, although it is also helpful in positional retention around bends in the vessel wall.
- One particular embodiment of the present invention provides for differentially machining a stent mesh pattern at one or more selected locations. These breaks are useful for imparting a particular desired degree of differential flexibility.
- Other objects of the present invention and many of the attendant advantages of the present invention will be readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, in which like reference numerals designate like parts throughout the figures thereof and wherein:
- FIG. 1 is a diagram schematically showing the overall medical procedure:
- FIG. 2 is a closeup view conceptually showing the operation of a vascular stent;
- FIG. 3A is a closeup view conceptually showing a stent machined into a mesh-like pattern;
- FIG. 3B is a closeup view of the mesh-like stent further machined with the channels of the present invention;
- FIG. 3C is a closeup view of particular sections of the stent of FIG. 3B;
- FIG. 4 is a very close up sectioned view of the contact between the longitudinally channeled stent element and the vessel wall;
- FIG. 5 is a view similar to FIG. 4 having a medication for chronic therapy;
- FIG. 6 is a very close up view of the contact between the laterally channeled stent element and the vessel wall;
- FIG. 7 is a view similar to FIG. 6 having a medication for chronic therapy;
- FIG. 8 is a very close up view of the contact between the laterally channeled stent element and the vessel wall showing differential flexibility around a bend in the vessel wall; and
- FIG. 9 is a view similar to that of FIG. 8 wherein the stent element has been machined into an articulated bridge.
- FIG. 1 is a diagram10 schematically showing the overall medical procedure. Patient 12 has experienced
occlusion 14 ofcoronary artery 16. This has caused insufficient perfusion tomyocardial tissue 18 of patient 12. To conduct the PTCA procedure known in the art, the distal portion of a catheter containing a dilation balloon and stent is percutaneously inserted atincision 22 and advanced throughartery 20 intocoronary artery 16 toocclusion 14.Occlusion 14 is opened and stented in the manner known in the art. - FIG. 2 is a closeup conceptual view of
stent 24 as place after dilatation of occlusion 14 (not shown).Stent 24 is generally cylindrical in shape having aninner lumen 26. Preferably,stent 24 is fabricated from thin, biocompatible tubing of stainless steel, titanium, or Nitinol. For coronary applications,stent 24 has a length of several millimeters to about one centimeter. A pattern (not shown in FIG. 2) is machined in the wall ofstent 24 as described below.Stent 24 has an outside diameter which is sized to snugly fit within the inner lumen ofcoronary artery 16 after dilatation. - FIG. 3A is a close-up view of
stent 24 as machined into a mesh-like pattern. Such machining removes much of the mass from the implanted stent. The mesh-like pattern increases flexibility of the stent and improves perfusion to the endothelial cells at the inside surface of the vessel wall. -
Stent element 28 appears as a portion of the generally cylindrical surface ofstent 24.Stent element 28 has a generally flat outer surface and a generally flat inner surface.Stent element 28 is preferably recessed in accordance with one of the embodiments of the present invention as described below in detail. - FIG. 3B is a closeup view of the mesh-like stent of FIG. 3A further machined to include pockets or channels in accordance with the present invention. As can be seen, the basic structure of the mesh-like pattern is a plurality of
cells 60 interconnected to provide the desired size. Eachcell 60 containsstrut 54 and internalradial arc 62. The cells are connected via connectingbridge 56. Articulatedbridge 58 is further machined as described in more detail below to enhance differential flexibility. The ends ofstent 24 are defined by a plurality of end radial arcs 64. Section AA provides a closeup (see FIG. 3C) of a machined channel. Section BB provides a closeup (see FIG. 3C) of a machined articulated bridge. - FIG. 3C is a closeup of Section AA, which is a machined channel, and Section BB, which is a machined articulated bridge.
- FIG. 4 is a very close-up sectioned view of stent element28 (the remainder of
stent 24 is not shown for clarity) as chronically implanted. As shown,stent element 28 is channeled in the longitudinal direction (i.e., direction of blood flow).Channel 30 is outwardly concave, as shown. This permits greater perfusion ofsurface 36 ofcoronary artery 16. Furthermore, edges 32 and 34 tend to prevent inadvertent repositioning during chronic implantation. - FIG. 5 is a view similar to that shown in FIG. 6 with the addition of
medication 38 withinchannel 30.Medication 38 is typically an anti-clotting agent, such as TPA, or an anti-irritant, such as a suitable steroid. The placement ofmedication 38 withinchannel 30 enhances chronic dispersion of the drug. - FIG. 6 is a view similar to FIG. 4, in which stent element28 (the remainder of
stent 24 is not shown for clarity) is channeled laterally (i.e., perpendicular to the direction of blood flow).Channel 44 is formed in the same manner as channel 30 (see also FIG. 4), but it is machined perpendicularly.Channel 44,edge 40, and edge 42 function in the same manner aschannel 30,edge 32, andedge 34. - FIG. 7 is a view similar to FIG. 6 wherein
channel 44 containsmedication 38. This embodiment functions similar to the embodiment of FIG. 5. - FIG. 8 is a view similar to FIG. 6 wherein
channel 44 is utilized to provide differential flexibility tostent element 28. This differential flexibility is important inaccommodating bend 46 ofvessel 16. This differential flexibility also assists in resisting inadvertent repositioning. - FIG. 9 is a view similar to FIG. 8 wherein
channel 40 has been machined deeply intostent element 28 and wherein thethin region 48 instent element 28 imparts a particular articulation instent 24. - Having thus described the preferred embodiments of the present invention, those of skill in the art will readily appreciate that the teachings found herein may be applied to yet other embodiments within the scope of the claims hereto attached.
Claims (21)
1. In a vascular stent having a generally cylindrical shape with an outer surface and an inner surface, the improvement comprising:
at least one channel in said outer surface.
2. The improvement according claim 1 wherein said channel is oriented generally parallel to said cylindrical shape.
3. The improvement according to claim 1 wherein said channel is oriented generally perpendicular to said cylindrical shape.
4. The improvement according to claim 1 wherein said stent is machined to produce a pattern having at least one stent element.
5. The improvement according to claim 4 wherein said channel is machined in one of said at least one stent element.
6. The improvement according to claim 5 wherein said channel contains a medication.
7. An apparatus comprising:
a. A vascular stent having a generally cylindrical shape and having an outer surface; and
b. A channel located on said outer surface.
8. An apparatus according to claim 7 wherein said vascular stent further comprises a stent element.
9. An apparatus according to claim 8 wherein said channel is located on said stent element.
10. An apparatus according to claim 9 wherein said channel is generally parallel to said cylindrical shape.
11. An apparatus according to claim 9 wherein said channel is generally perpendicular to said cylindrical shape.
12. A method of preparing a vascular stent comprising:
a. Securing a bio-compatible tube having a generally cylindrical shape with an outer surface; and
b. Providing a channel in said outer surface.
13. A method according to claim 12 further comprising creating a pattern in said bio-compatible tube producing a stent element.
14. A method according to claim 13 wherein said providing step further comprises machining said channel into said stent element.
15. A method according to claim 14 further comprising the step of embedding a medication into said channel.
16. An apparatus comprising:
a. Means for stenting a vessel having an outer surface; and
b. Means located on said outer surface for enhancing perfusion.
17. An apparatus according to claim 16 further comprising means responsively coupled to said outer surface for imparting differential flexiblity.
18. An apparatus according to claim 16 wherein said enhancing means further comprises a channel within said outer surface.
19. An apparatus according to claim 18 wherein said outer surface has a pattern producing a stent element.
20. An apparatus according to claim 19 wherein said channel is located on said stent element in a generally parallel direction.
21. An apparatus according to claim 19 wherein said channel is located on said stent element in a generally perpendicular direction.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/806,263 US20040181275A1 (en) | 2000-07-14 | 2004-03-22 | Channeled vascular stent apparatus and method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/616,274 US6709451B1 (en) | 2000-07-14 | 2000-07-14 | Channeled vascular stent apparatus and method |
US10/806,263 US20040181275A1 (en) | 2000-07-14 | 2004-03-22 | Channeled vascular stent apparatus and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/616,274 Continuation US6709451B1 (en) | 2000-07-14 | 2000-07-14 | Channeled vascular stent apparatus and method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040181275A1 true US20040181275A1 (en) | 2004-09-16 |
Family
ID=24468730
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/616,274 Expired - Fee Related US6709451B1 (en) | 2000-07-14 | 2000-07-14 | Channeled vascular stent apparatus and method |
US10/806,263 Abandoned US20040181275A1 (en) | 2000-07-14 | 2004-03-22 | Channeled vascular stent apparatus and method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/616,274 Expired - Fee Related US6709451B1 (en) | 2000-07-14 | 2000-07-14 | Channeled vascular stent apparatus and method |
Country Status (4)
Country | Link |
---|---|
US (2) | US6709451B1 (en) |
EP (1) | EP1172074A3 (en) |
JP (1) | JP2002065862A (en) |
CA (1) | CA2353197A1 (en) |
Cited By (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8597367B2 (en) | 2006-06-16 | 2013-12-03 | Boston Scientific Scimed, Inc. | Partially soluble implantable or insertable medical devices |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
CN110811735A (en) * | 2019-11-21 | 2020-02-21 | 中国科学院金属研究所 | Locally-enhanced nickel-titanium alloy intracranial support |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040254635A1 (en) | 1998-03-30 | 2004-12-16 | Shanley John F. | Expandable medical device for delivery of beneficial agent |
US7208010B2 (en) | 2000-10-16 | 2007-04-24 | Conor Medsystems, Inc. | Expandable medical device for delivery of beneficial agent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
KR100819895B1 (en) | 2000-10-16 | 2008-04-07 | 코너 메드시스템즈 인코포레이티드 | Expandable medical device for delivery of beneficial agent |
US6752829B2 (en) * | 2001-01-30 | 2004-06-22 | Scimed Life Systems, Inc. | Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same |
US20040073294A1 (en) | 2002-09-20 | 2004-04-15 | Conor Medsystems, Inc. | Method and apparatus for loading a beneficial agent into an expandable medical device |
AU2002233342B2 (en) | 2001-02-16 | 2007-10-25 | Abbott Laboratories Vascular Enterprises Limited | Implants with FK506 for prophylaxis and treatment of restonoses |
DE10118944B4 (en) * | 2001-04-18 | 2013-01-31 | Merit Medical Systems, Inc. | Removable, essentially cylindrical implants |
DE60236093D1 (en) * | 2001-07-26 | 2010-06-02 | Merit Medical Systems Inc | REMOVABLE STENT |
US7842083B2 (en) | 2001-08-20 | 2010-11-30 | Innovational Holdings, Llc. | Expandable medical device with improved spatial distribution |
AU2003250913A1 (en) * | 2002-07-08 | 2004-01-23 | Abbott Laboratories Vascular Enterprises Limited | Drug eluting stent and methods of manufacture |
US7758636B2 (en) | 2002-09-20 | 2010-07-20 | Innovational Holdings Llc | Expandable medical device with openings for delivery of multiple beneficial agents |
US20040093056A1 (en) * | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7527644B2 (en) * | 2002-11-05 | 2009-05-05 | Alveolus Inc. | Stent with geometry determinated functionality and method of making the same |
US7959671B2 (en) * | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7637942B2 (en) * | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
EP2272544A1 (en) | 2003-03-28 | 2011-01-12 | Conor Medsystems, Inc. | Implantable medical device with beneficial agent concentration gradient |
US7637934B2 (en) * | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US7604660B2 (en) * | 2003-05-01 | 2009-10-20 | Merit Medical Systems, Inc. | Bifurcated medical appliance delivery apparatus and method |
US7785653B2 (en) | 2003-09-22 | 2010-08-31 | Innovational Holdings Llc | Method and apparatus for loading a beneficial agent into an expandable medical device |
US8398670B2 (en) * | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US8313505B2 (en) * | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US9039724B2 (en) * | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
WO2005122959A2 (en) | 2004-06-08 | 2005-12-29 | Advanced Stent Technologies, Inc. | Stent with protruding branch portion for bifurcated vessels |
US8900287B2 (en) * | 2006-01-13 | 2014-12-02 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US8778008B2 (en) * | 2006-01-13 | 2014-07-15 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of vascular abnormalities |
US20080140179A1 (en) * | 2006-12-12 | 2008-06-12 | Ladisa John F | Apparatus and method for minimizing flow disturbances in a stented region of a lumen |
US7682388B2 (en) * | 2007-01-30 | 2010-03-23 | Medtronic Vascular, Inc. | Stent with longitudinal groove |
US20090076591A1 (en) * | 2007-09-19 | 2009-03-19 | Boston Scientific Scimed, Inc. | Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface |
US8016880B2 (en) * | 2007-11-16 | 2011-09-13 | Medtronic Vascular, Inc. | Stent having spiral channel for drug delivery |
US7833266B2 (en) * | 2007-11-28 | 2010-11-16 | Boston Scientific Scimed, Inc. | Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment |
US8163004B2 (en) * | 2008-02-18 | 2012-04-24 | Aga Medical Corporation | Stent graft for reinforcement of vascular abnormalities and associated method |
US7951193B2 (en) * | 2008-07-23 | 2011-05-31 | Boston Scientific Scimed, Inc. | Drug-eluting stent |
WO2010048052A1 (en) | 2008-10-22 | 2010-04-29 | Boston Scientific Scimed, Inc. | Shape memory tubular stent with grooves |
CN101732114B (en) * | 2008-11-04 | 2014-07-30 | 上海微创医疗器械(集团)有限公司 | Coronary artery stent with medicine carrying grooves |
US9615948B2 (en) | 2010-04-26 | 2017-04-11 | Medtronic Vascular, Inc. | Drug eluting folded stent and stent delivery system |
US9039752B2 (en) | 2011-09-20 | 2015-05-26 | Aga Medical Corporation | Device and method for delivering a vascular device |
US8621975B2 (en) | 2011-09-20 | 2014-01-07 | Aga Medical Corporation | Device and method for treating vascular abnormalities |
EP3735936B1 (en) | 2014-10-09 | 2023-11-29 | Boston Scientific Scimed, Inc. | Mandrel and method of forming an expandable stent structure |
US11559412B2 (en) | 2019-01-07 | 2023-01-24 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
KR20230116879A (en) | 2020-12-02 | 2023-08-04 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | Stents with improved deployment properties |
CN115624422B (en) * | 2022-12-19 | 2023-04-07 | 北京心祐医疗科技有限公司 | Blood vessel support |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071305A (en) * | 1996-11-25 | 2000-06-06 | Alza Corporation | Directional drug delivery stent and method of use |
US6190404B1 (en) * | 1997-11-07 | 2001-02-20 | Advanced Bio Prosthetic Surfaces, Ltd. | Intravascular stent and method for manufacturing an intravascular stent |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4307723A (en) | 1978-04-07 | 1981-12-29 | Medical Engineering Corporation | Externally grooved ureteral stent |
US5500013A (en) * | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
ATE188863T1 (en) | 1994-02-25 | 2000-02-15 | Fischell Robert | STENT |
US5891108A (en) | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
US5681345A (en) * | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
US5591197A (en) * | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
CA2178541C (en) * | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US5718713A (en) | 1997-04-10 | 1998-02-17 | Global Therapeutics, Inc. | Surgical stent having a streamlined contour |
US5843172A (en) | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US5972027A (en) * | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US5989207A (en) | 1997-11-03 | 1999-11-23 | Hughes; Boyd R. | Double swirl stent |
US6132461A (en) * | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
DE19906956B4 (en) | 1999-02-19 | 2011-07-21 | QualiMed Innovative Medizin-Produkte GmbH, 21423 | Stent and method for producing a stent |
US6379381B1 (en) * | 1999-09-03 | 2002-04-30 | Advanced Cardiovascular Systems, Inc. | Porous prosthesis and a method of depositing substances into the pores |
US6254632B1 (en) * | 2000-09-28 | 2001-07-03 | Advanced Cardiovascular Systems, Inc. | Implantable medical device having protruding surface structures for drug delivery and cover attachment |
-
2000
- 2000-07-14 US US09/616,274 patent/US6709451B1/en not_active Expired - Fee Related
-
2001
- 2001-07-13 CA CA002353197A patent/CA2353197A1/en not_active Abandoned
- 2001-07-13 EP EP01401891A patent/EP1172074A3/en not_active Withdrawn
- 2001-07-16 JP JP2001215181A patent/JP2002065862A/en active Pending
-
2004
- 2004-03-22 US US10/806,263 patent/US20040181275A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071305A (en) * | 1996-11-25 | 2000-06-06 | Alza Corporation | Directional drug delivery stent and method of use |
US6190404B1 (en) * | 1997-11-07 | 2001-02-20 | Advanced Bio Prosthetic Surfaces, Ltd. | Intravascular stent and method for manufacturing an intravascular stent |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8597367B2 (en) | 2006-06-16 | 2013-12-03 | Boston Scientific Scimed, Inc. | Partially soluble implantable or insertable medical devices |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US8715339B2 (en) | 2006-12-28 | 2014-05-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
CN110811735A (en) * | 2019-11-21 | 2020-02-21 | 中国科学院金属研究所 | Locally-enhanced nickel-titanium alloy intracranial support |
Also Published As
Publication number | Publication date |
---|---|
EP1172074A2 (en) | 2002-01-16 |
CA2353197A1 (en) | 2002-01-14 |
JP2002065862A (en) | 2002-03-05 |
EP1172074A3 (en) | 2003-02-19 |
US6709451B1 (en) | 2004-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6709451B1 (en) | Channeled vascular stent apparatus and method | |
US7632304B2 (en) | Coronary stent | |
US6953476B1 (en) | Device and method for treating ischemic heart disease | |
US8882822B2 (en) | Non-thrombogenic stent jacket | |
JP3761967B2 (en) | sheath | |
US5776183A (en) | Expandable stent | |
US7314484B2 (en) | Methods and devices for treating aneurysms | |
AU2005269663B2 (en) | Stent with an end member having a lateral extension | |
AU2002228855B2 (en) | Stent for treating in-stent restenosis | |
JP5054524B2 (en) | Stent with protruding branch for branch pipe | |
JP3754125B2 (en) | Intravascular multi-anchor stent | |
JP2940859B2 (en) | Shape memory lock mechanism for intravascular stent | |
EP2656818B1 (en) | Absorbable blood vessel stent | |
EP1363694B1 (en) | Catheter assembly with substantially circular dual balloons | |
WO2004064911A1 (en) | Stent for percutaneous coronary intervention, coated with vascular restenosis prevention drug | |
JP2007523677A (en) | Method and system for treating side branch ostium | |
US20110152994A1 (en) | Implantable device | |
US10736759B2 (en) | Medical stent | |
US20030097170A1 (en) | Implantation device for an aorta in an aortic arch | |
WO1999036015A1 (en) | Catheter and method of ostial stent placement | |
JP4727063B2 (en) | Bifurcated stent and stent deployment system | |
WO2004021929A1 (en) | Modular stent system and delivery means | |
KR20230058075A (en) | Tissue restoration device and method | |
CN113952094A (en) | Detachable branch support for bifurcation | |
JP2004512920A (en) | Endovascular prosthesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |